Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
1.2.3 Positron Emission Tomography (PET) Radiopharmaceuticals
1.3 Market by Application
1.3.1 Global SPECT and PET Radiopharmaceuticals Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global SPECT and PET Radiopharmaceuticals Market Perspective (2018-2029)
2.2 SPECT and PET Radiopharmaceuticals Growth Trends by Region
2.2.1 Global SPECT and PET Radiopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 SPECT and PET Radiopharmaceuticals Historic Market Size by Region (2018-2024)
2.2.3 SPECT and PET Radiopharmaceuticals Forecasted Market Size by Region (2024-2029)
2.3 SPECT and PET Radiopharmaceuticals Market Dynamics
2.3.1 SPECT and PET Radiopharmaceuticals Industry Trends
2.3.2 SPECT and PET Radiopharmaceuticals Market Drivers
2.3.3 SPECT and PET Radiopharmaceuticals Market Challenges
2.3.4 SPECT and PET Radiopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top SPECT and PET Radiopharmaceuticals Players by Revenue
3.1.1 Global Top SPECT and PET Radiopharmaceuticals Players by Revenue (2018-2024)
3.1.2 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Players (2018-2024)
3.2 Global SPECT and PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by SPECT and PET Radiopharmaceuticals Revenue
3.4 Global SPECT and PET Radiopharmaceuticals Market Concentration Ratio
3.4.1 Global SPECT and PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SPECT and PET Radiopharmaceuticals Revenue in 2022
3.5 SPECT and PET Radiopharmaceuticals Key Players Head office and Area Served
3.6 Key Players SPECT and PET Radiopharmaceuticals Product Solution and Service
3.7 Date of Enter into SPECT and PET Radiopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SPECT and PET Radiopharmaceuticals Breakdown Data by Type
4.1 Global SPECT and PET Radiopharmaceuticals Historic Market Size by Type (2018-2024)
4.2 Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Type (2024-2029)
5 SPECT and PET Radiopharmaceuticals Breakdown Data by Application
5.1 Global SPECT and PET Radiopharmaceuticals Historic Market Size by Application (2018-2024)
5.2 Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
6.2 North America SPECT and PET Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024)
6.4 North America SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
7.2 Europe SPECT and PET Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024)
7.4 Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
8.2 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2024)
8.4 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
9.2 Latin America SPECT and PET Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024)
9.4 Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size (2018-2029)
10.2 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024)
10.4 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare SPECT and PET Radiopharmaceuticals Introduction
11.1.4 GE Healthcare Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.1.5 GE Healthcare Recent Development
11.2 Cardinal Health
11.2.1 Cardinal Health Company Detail
11.2.2 Cardinal Health Business Overview
11.2.3 Cardinal Health SPECT and PET Radiopharmaceuticals Introduction
11.2.4 Cardinal Health Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.2.5 Cardinal Health Recent Development
11.3 Curium Pharma
11.3.1 Curium Pharma Company Detail
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma SPECT and PET Radiopharmaceuticals Introduction
11.3.4 Curium Pharma Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.3.5 Curium Pharma Recent Development
11.4 China Isotope & Radiation
11.4.1 China Isotope & Radiation Company Detail
11.4.2 China Isotope & Radiation Business Overview
11.4.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Introduction
11.4.4 China Isotope & Radiation Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.4.5 China Isotope & Radiation Recent Development
11.5 Jubilant Life Sciences
11.5.1 Jubilant Life Sciences Company Detail
11.5.2 Jubilant Life Sciences Business Overview
11.5.3 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Introduction
11.5.4 Jubilant Life Sciences Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.5.5 Jubilant Life Sciences Recent Development
11.6 Bracco
11.6.1 Bracco Company Detail
11.6.2 Bracco Business Overview
11.6.3 Bracco SPECT and PET Radiopharmaceuticals Introduction
11.6.4 Bracco Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.6.5 Bracco Recent Development
11.7 Yantai Dongcheng Pharmaceutical
11.7.1 Yantai Dongcheng Pharmaceutical Company Detail
11.7.2 Yantai Dongcheng Pharmaceutical Business Overview
11.7.3 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Introduction
11.7.4 Yantai Dongcheng Pharmaceutical Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.7.5 Yantai Dongcheng Pharmaceutical Recent Development
11.8 Lantheus Medical Imaging, Inc.
11.8.1 Lantheus Medical Imaging, Inc. Company Detail
11.8.2 Lantheus Medical Imaging, Inc. Business Overview
11.8.3 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Introduction
11.8.4 Lantheus Medical Imaging, Inc. Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.8.5 Lantheus Medical Imaging, Inc. Recent Development
11.9 Eczacıbaşı Monrol Nuclear Products
11.9.1 Eczacıbaşı Monrol Nuclear Products Company Detail
11.9.2 Eczacıbaşı Monrol Nuclear Products Business Overview
11.9.3 Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Introduction
11.9.4 Eczacıbaşı Monrol Nuclear Products Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.9.5 Eczacıbaşı Monrol Nuclear Products Recent Development
11.10 Novartis International AG
11.10.1 Novartis International AG Company Detail
11.10.2 Novartis International AG Business Overview
11.10.3 Novartis International AG SPECT and PET Radiopharmaceuticals Introduction
11.10.4 Novartis International AG Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.10.5 Novartis International AG Recent Development
11.11 Siemens
11.11.1 Siemens Company Detail
11.11.2 Siemens Business Overview
11.11.3 Siemens SPECT and PET Radiopharmaceuticals Introduction
11.11.4 Siemens Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024)
11.11.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
Table 3. Key Players of Positron Emission Tomography (PET) Radiopharmaceuticals
Table 4. Global SPECT and PET Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global SPECT and PET Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global SPECT and PET Radiopharmaceuticals Market Share by Region (2018-2024)
Table 8. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global SPECT and PET Radiopharmaceuticals Market Share by Region (2024-2029)
Table 10. SPECT and PET Radiopharmaceuticals Market Trends
Table 11. SPECT and PET Radiopharmaceuticals Market Drivers
Table 12. SPECT and PET Radiopharmaceuticals Market Challenges
Table 13. SPECT and PET Radiopharmaceuticals Market Restraints
Table 14. Global SPECT and PET Radiopharmaceuticals Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global SPECT and PET Radiopharmaceuticals Market Share by Players (2018-2024)
Table 16. Global Top SPECT and PET Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT and PET Radiopharmaceuticals as of 2022)
Table 17. Ranking of Global Top SPECT and PET Radiopharmaceuticals Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by SPECT and PET Radiopharmaceuticals Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players SPECT and PET Radiopharmaceuticals Product Solution and Service
Table 21. Date of Enter into SPECT and PET Radiopharmaceuticals Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2018-2024)
Table 25. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2024-2029)
Table 27. Global SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2018-2024)
Table 29. Global SPECT and PET Radiopharmaceuticals Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2024-2029)
Table 31. North America SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 46. GE Healthcare Company Detail
Table 47. GE Healthcare Business Overview
Table 48. GE Healthcare SPECT and PET Radiopharmaceuticals Product
Table 49. GE Healthcare Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 50. GE Healthcare Recent Development
Table 51. Cardinal Health Company Detail
Table 52. Cardinal Health Business Overview
Table 53. Cardinal Health SPECT and PET Radiopharmaceuticals Product
Table 54. Cardinal Health Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 55. Cardinal Health Recent Development
Table 56. Curium Pharma Company Detail
Table 57. Curium Pharma Business Overview
Table 58. Curium Pharma SPECT and PET Radiopharmaceuticals Product
Table 59. Curium Pharma Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 60. Curium Pharma Recent Development
Table 61. China Isotope & Radiation Company Detail
Table 62. China Isotope & Radiation Business Overview
Table 63. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product
Table 64. China Isotope & Radiation Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 65. China Isotope & Radiation Recent Development
Table 66. Jubilant Life Sciences Company Detail
Table 67. Jubilant Life Sciences Business Overview
Table 68. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product
Table 69. Jubilant Life Sciences Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 70. Jubilant Life Sciences Recent Development
Table 71. Bracco Company Detail
Table 72. Bracco Business Overview
Table 73. Bracco SPECT and PET Radiopharmaceuticals Product
Table 74. Bracco Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 75. Bracco Recent Development
Table 76. Yantai Dongcheng Pharmaceutical Company Detail
Table 77. Yantai Dongcheng Pharmaceutical Business Overview
Table 78. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product
Table 79. Yantai Dongcheng Pharmaceutical Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 80. Yantai Dongcheng Pharmaceutical Recent Development
Table 81. Lantheus Medical Imaging, Inc. Company Detail
Table 82. Lantheus Medical Imaging, Inc. Business Overview
Table 83. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product
Table 84. Lantheus Medical Imaging, Inc. Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 85. Lantheus Medical Imaging, Inc. Recent Development
Table 86. Eczacıbaşı Monrol Nuclear Products Company Detail
Table 87. Eczacıbaşı Monrol Nuclear Products Business Overview
Table 88. Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product
Table 89. Eczacıbaşı Monrol Nuclear Products Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 90. Eczacıbaşı Monrol Nuclear Products Recent Development
Table 91. Novartis International AG Company Detail
Table 92. Novartis International AG Business Overview
Table 93. Novartis International AG SPECT and PET Radiopharmaceuticals Product
Table 94. Novartis International AG Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 95. Novartis International AG Recent Development
Table 96. Siemens Company Detail
Table 97. Siemens Business Overview
Table 98. Siemens SPECT and PET Radiopharmaceuticals Product
Table 99. Siemens Revenue in SPECT and PET Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 100. Siemens Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global SPECT and PET Radiopharmaceuticals Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global SPECT and PET Radiopharmaceuticals Market Share by Type: 2022 VS 2029
Figure 3. Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals Features
Figure 4. Positron Emission Tomography (PET) Radiopharmaceuticals Features
Figure 5. Global SPECT and PET Radiopharmaceuticals Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global SPECT and PET Radiopharmaceuticals Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. SPECT and PET Radiopharmaceuticals Report Years Considered
Figure 11. Global SPECT and PET Radiopharmaceuticals Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global SPECT and PET Radiopharmaceuticals Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global SPECT and PET Radiopharmaceuticals Market Share by Region: 2022 VS 2029
Figure 14. Global SPECT and PET Radiopharmaceuticals Market Share by Players in 2022
Figure 15. Global Top SPECT and PET Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT and PET Radiopharmaceuticals as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by SPECT and PET Radiopharmaceuticals Revenue in 2022
Figure 17. North America SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America SPECT and PET Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 19. United States SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe SPECT and PET Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 23. Germany SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific SPECT and PET Radiopharmaceuticals Market Share by Region (2018-2029)
Figure 31. China SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America SPECT and PET Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 39. Mexico SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 43. Turkey SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia SPECT and PET Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. GE Healthcare Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 46. Cardinal Health Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 47. Curium Pharma Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 48. China Isotope & Radiation Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 49. Jubilant Life Sciences Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 50. Bracco Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 51. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 52. Lantheus Medical Imaging, Inc. Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 53. Eczacıbaşı Monrol Nuclear Products Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 54. Novartis International AG Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 55. Siemens Revenue Growth Rate in SPECT and PET Radiopharmaceuticals Business (2018-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed